metricas
covid
Buscar en
Revista de Senología y Patología Mamaria - Journal of Senology and Breast Disease
Toda la web
Inicio Revista de Senología y Patología Mamaria - Journal of Senology and Breast Dise... Granular cell tumor: An Italian case-report
Información de la revista
Vol. 35. Núm. S1.
Controversias en patología mamaria
Páginas S22-S24 (marzo 2022)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1254
Vol. 35. Núm. S1.
Controversias en patología mamaria
Páginas S22-S24 (marzo 2022)
Case report
Acceso a texto completo
Granular cell tumor: An Italian case-report
Tumor de células granulares: caso clínico en Italia
Visitas
1254
Federico Ghidinellia,
Autor para correspondencia
federicoghidinelli@hotmail.it

Corresponding author.
, Luigi Filippinib, Paola Porsiob, Federico Canzib, Anna Bianchib
a Spedali Civili di Brescia, Brescia, Italy
b Department of surgery, Spedali Civili di Brescia, Brescia, Italy
Contenido relacionado
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (2)
Suplemento especial
Este artículo forma parte de:
Vol. 35. Núm S1

Controversias en patología mamaria

Más datos
Abstract

We report a case of a 58-year-old woman with granular cell tumor (GCT) of the breast. The clinical and instrumental aspects were suggestive for breast cancer.

The correct diagnosis was obtained with a paraffin histological examination of the lesion excised by the biopsy.

The clinical peculiarities and the correlated therapeutic implications of this rare neoplasm are discussed in this manuscript.

Although CGT is a rare condition, it has considerable importance among benign breast lesions that can be erroneously interpreted as carcinoma.

Keywords:
Granular cell tumor
Breast cancer
Breast granular cell tumor management
Resumen

Reportamos el caso de una mujer de 58 años de edad con tumor de células granulares (TCG) en la mama. Los aspectos clínico e instrumental eran indicativos de cáncer de mama.

El diagnóstico correcto se obtuvo mediante examen histológico en parafina de la lesión extirpada mediante biopsia.

En el presente documento se debaten las peculiaridades clínicas y las implicaciones terapéuticas consiguientes de esta neoplasia infrecuente.

Aunque el TCG es una situación rara, tiene una importancia considerable entre las lesiones benignas de mama que pueden interpretarse erróneamente como carcinoma.

Palabras clave:
Tumor de células granulares
Cáncer de mama
Manejo del tumor de células granulares en la mama
Texto completo
Introduction

Granular cell tumor (GCT) is a rare soft tissue neoplasm, described for the first time in 1926 by Abrikossoff with the name of “granular cell mioblastoma”.1

Although the histogenesis is still object of debate, recent histochemical studies and ultrastructural findings support the origin of this neoplasm from the peripheral nervous tissue, most likely from Schwann's cells.2

This tumor is mainly localized in several anatomical positions, comprising the tongue and the skin.3

A total percentage of 6–8% of all cases arises from the breast, mostly in women between 30 and 50 years old.

Although the granular cell tumor of the breast is a rare entity, surgeons and pathologists should be aware of its existence to avoid inappropriate radical surgery not justified by the benign behavior of the neoplasm.

We present a case of a patient with GCT.

Clinical case

A 58 years-old woman presented to our department after a mammographic screening.

Physical examination showed a breast mass in the right breast with all features of malignancy on palpation.

The mammography revealed a suspicious 7mm×6mm nodular formation with irregular margins, localized in the upper outer quadrant of the right breast.

The lesion was typified with vacuum assisted biopsy (VAB) and it resulted to be a granular cell tumor (GCT) of the breast.

The suspect neoplasia was centered with a second metallic wire allowing the right surgical removal, confirmed at the radiological control.

The definitive histologic exam confirmed the first stereotactic vacuum assisted biopsy's diagnosis of GTC tumor, strongly and diffusely positive to S100 and PGM1, resulting negative for broad-spectrum cytokeratin.

No adverse events were reported during the performance of these medical procedures.

Finally, she has been followed by a multidisciplinary team at regular intervals, including a clinical follow-up every 3/6 months for the first two years and every year until five years after surgery.

At the most recent follow-up, the patient remains without evidence of disease on clinical examination and medical imaging (Figs. 1 and 2).

Figure 1.

Mammographic image showing the metallic marker at the site of breast lesion.

(0.07MB).
Figure 2.

The histologic sample of the removed lesion with the metallic marker.

(0.03MB).
Discussion

The GCT histopathology has been argued for a long time, although the first wrong Abrikossoff's origin supposition from the striated muscle tissue.4

Several authors attributed the GCT a neural origin from Shwann's cell, based on the structural and histochemical studies based on the positivity to S100 protein and negativity to cytokeratin, an epithelial cell marker.5

The most frequent localization of this tumor in the breast is in the upper outer quadrant, as confirmed in our case.

More than half of patients with GCT present with a hard and painless nodule, indistinct areas and skin retraction signs.

A third of cases resemble a fibroadenoma, while in less than 10% of cases there isn’t any sign of clinical expression.

This kind of lesion can simulate a fibroadenoma during physical examination.

In addition, radiologic images can be not indicative of a CGT and they have several features that can mimic a radial scar.

The only possibility to find the CGT is during screening or in the surgical piece.

Even in our situation, as in the 60% of cases, mammography shows a nodular opacity with irregular margins, suggesting a malignant neoplasm.

Although the GCT of the breast may be considered a rare lesion, it is of considerable importance in the differential diagnosis with breast cancer.

In our case-report it appears to be the first case reported recently.

The clinical case in question, despite the diagnosis already in possession at the time of presentation, allows us to state that the neoplasm manifests itself with clinical radiological features of malignancy like other injuries such as “radial scar”.

The GCT is a benign neoplasm almost always treatable by surgical excision. However, since local recurrences have been documented in patients undergoing inadequate excision, a clinical-instrumental follow-up is recommended.

Funding

There is no funding for this scientific study.

Confidentiality of data

The authors declare that they have followed the protocols of their center on the publication of patient data.

Conflicts of interest

There are no conflicts of interests among authors.

References
[1]
G. Canlorbe, S. Bendifallah.
Prise en charge des tumeurs du sein bénignes épidémiologiquement rares de type Abrikossoff (tumeur à cellules granuleuses), adénomatose érosive du mamelon, cytosteátonécrose, fibromatose mammaire (tumeur desmoïde), galactocèle, hamartome, hémangiome, lipo.
J Gynecol Obstet Biol la Reprod, 44 (2015), pp. 1030-1048
[2]
D.M. Jagannathan.
Benign granular-cell tumor of the breast: case report and literature review.
Radiol Case Rep, 10 (2015), pp. 1116
[3]
M. Mobarki, J.M. Dumollard, P. Dal Col, F. Camy, M. Peoc’h, G. Karpathiou.
Granular cell tumor a study of 42 cases and systemic review of the literature.
Pathol Res Pract, 216 (2020), pp. 152865
[4]
B. Rexeena, A. Paul, R.A. Nitish, C. Kurian, R.K. Anila.
Granular cell tumor of breast: a case report and review of literature.
Indian J Surg Oncol, 6 (2015), pp. 446-448
[5]
X. Qian, Y. Chen, F. Wan.
Granular cell tumor of the breast during lactation: a case report and review of the literature.
Oncol Lett, 8 (2014), pp. 2565-2568
Copyright © 2021. SESPM
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.senol.2024.100600
No mostrar más